Found 382 matching trials
Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer NA This clinical trial studies fludarabine phosphate, low-dose total body irra...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia PHASE2 The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Show More Location
University of Michigan Cancer Center
Learn More & Join Trial
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression PHASE2 Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Show More Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor PHASE2 This is a Phase II, open-label, two strata, multicenter, prospective study ...
Show More Location
H. Lee Moffitt Cancer Center
Learn More & Join Trial
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation PHASE2 This is a prospective, single-arm, phase II study. Patients will be treated...
Show More Location
Chao Family Comprehensive Cancer Center, University of California Irvine
Learn More & Join Trial
ALL-SCT BFM International- HSCT in Children and Adolescents With ALL PHASE3 With this protocol the ALL-SCT BFM international study group wants
* to ev...
Show More Location
Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie
Learn More & Join Trial
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps PHASE1 This is a research study involving the treatment of patients with hematolog...
Show More Location
Thomas Jefferson University
Learn More & Join Trial
Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML PHASE2 RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and total...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years PHASE2 Outcomes for adult patients with Severe Aplastic Anemia (SAA) aged more tha...
Show More Location
Saint Louis hospital
Learn More & Join Trial